ARV Facts

Facts about Antiretroviral Drugs

Arrow to the left Back to the Homepage

Active substance: Fosamprenavir
Manufacturer: GlaxoSmithKline (UK)

Extract from the prescribing information:

"Patients should be informed that LEXIVA is not a cure for HIV infection and that they may continue to develop opportunistic infections and other complications associated with HIV disease. The long-term effects of LEXIVA are unknown at this time. Patients should be told that there are currently no data demonstrating that therapy with LEXIVA can reduce the risk of transmitting HIV to others."

Known side effects: more immune deficiency

“A complete blood count should be performed weekly and as clinically indicated to monitor for neutropenia.”

Neutropenia = Decrease of neutrophils, a subtype of white blood cells

The above has been extracted from the Lexiva prescribing information on the GlaxoSmithKline webpages.